化学外体衍生的免疫调节器恢复淋巴结的微环境,以提高TNBC免疫疗法的敏感性
Mengchi Sun1,2,3, Yuxia Wu1, Zhichao Chen4
1Department of Pharmacy, The First Hospital of China Medical University, Shenyang, Liaoning, China.
Nature communications
|August 2, 2025
概括
这项研究开发了一种新的免疫调节剂,以改善三阴性乳腺癌 (TNBC) 的免疫疗法. 它准瘤微环境,增强树突细胞功能,促进抗癌免疫反应,以获得更好的治疗结果.
科学领域:
- 生物医学工程 生物医学工程
- 癌症研究 癌症研究
- 免疫学 免疫学 免疫学
背景情况:
- 免疫疗法对三阴性乳腺癌 (TNBC) 是有前途的,但在许多患者中有效性有限.
- 免疫抑制性淋巴结 (LN) 微环境中的功能失调的树突细胞 (DCs),与高反应性氧物种 (ROS) 和脂质失衡有关,阻碍了TNBC免疫治疗.
- 优化LN微环境对于增强TNBC免疫治疗反应至关重要.
研究的目的:
- 开发一种基于外体的新型仿真免疫调节剂,以克服TNBC的免疫疗法耐药性.
- 恢复DC功能,改善TNBC中的免疫抑制性LN微环境.
- 通过解决ROS和脂质平衡,提高TNBC免疫疗法的疗效.
主要方法:
- 通过使用聚硫化键桥接的半孔芯,托约卡米和奇米外体 (DCs衍生外体和沙门氏菌外膜囊泡) 构建了一种多方面的免疫调节器.
- 通过同源向和化学导,设计了免疫调节器以增强LN定位.
- 利用ROS反应性药物释放来恢复DC和LN免疫微环境功能.
主要成果:
- 免疫调节器显著改善了TNBC对免疫疗法的反应.
- 观察到主要瘤生长和转移的强烈抑制.
- 在LNs中实现了中央记忆T细胞的大幅增加,促进了持续的抗瘤免疫力.
结论:
- 开发的免疫调节器有效地优化了TNBC中的LN微环境.
- 这一策略通过恢复DC功能和免疫记忆,显著提高了TNBC的免疫疗法疗效.
- 这项研究为转化免疫疗法在TNBC治疗中提供了一种有希望的方法.
更多相关视频
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
14.8K
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.5K
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660